市場調查報告書
商品編碼
1468362
治療床市場報告(按產品(臨床床、家用床、配件)、應用(急診床、重症護理床、長期床)、最終用戶(醫院和診所、生殖護理中心等)和地區 2024 -2032Therapeutic Beds Market Report by Product (Clinical Beds, Household Beds, Accessories), Application (Acute Care Beds, Critical Care Beds, Long-term Beds), End User (Hospital and Clinics, Reproductive Care Centers, and Others), and Region 2024-2032 |
IMARC Group年全球治療床市場規模達45億美元。
臨床治療床是專門設計的床,可提供最大程度的患者舒適度並改善醫療服務。這些床旨在用於受控的臨床環境,例如療養院、診斷實驗室和門診診所。這些可調式床還包括額外的定位輔助工具,例如墊子、枕頭和楔子。與普通床相比,這些床和床墊的設計目的是降低穴位、調節體溫、預防褥瘡和改善血液流動。除此之外,它們還配備了先進的功能,如電子升降、側軌和輪子,從而為患者提供攜帶性和安全性。如果發生手術、受傷或退化性疾病,治療床可以滿足與醫療狀況相關的舒適度和定位需求。
全球市場主要由醫療保健領域的持續技術進步所推動。這可以歸因於主要參與者所進行的廣泛的研發(R&D)活動,重點是推出創新產品變體。除此之外,消費者對健康和保健意識的大幅提高是市場成長的重要推動因素。容易患多種慢性疾病並需要更長住院時間的老年人口數量不斷增加,進一步推動了市場的發展。與此一致的是,不斷擴大的醫療支出以及公共和私人機構為改善整體醫療基礎設施而提供的資金不斷增加,也是其他主要的成長誘導因素。影響市場的其他一些因素包括術前和術後重症監護服務的需求不斷增加、生活方式相關疾病的患病率上升、患者護理支出的增加以及為改善床位與患者比例而增加的投資。
The global therapeutic beds market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.23% during 2024-2032.
Clinical therapeutic beds are specially designed beds that provide maximum patient comfort and improve healthcare delivery. These beds are intended to be used in controlled clinical environments, such as nursing homes, diagnostic laboratories, and outpatient clinics. Additional positioning aids, such as pads, pillows, and wedges, are also included with these adjustable beds. When compared to regular beds, these beds and mattresses are designed to lower acupoints, regulate body temperature, prevent bedsores, and improve blood flow. In addition to this, they are equipped with advanced features, such as electronic elevation, side rails, and wheels, thereby providing portability and safety for patients. In the event of surgery, injury, or degenerative disease, therapy beds fulfill the comfort and positioning needs associated with the medical condition.
The global market is majorly driven by continual technological advancements in the healthcare sector. This can be attributed to the extensive research and development (R&D) activities conducted by the key players focusing on introducing innovative product variants. In addition to this, a considerable rise in consumer awareness regarding health and wellness is acting as a significant growth-inducing factor for the market. The market is further propelled by the rising geriatric population susceptible to developing several chronic illnesses and requiring longer hospital stays. In line with this, the expanding medical expenditure and growing funding by public and private agencies to improve the overall healthcare infrastructure are acting as other major growth-inducing factors. Some of the other factors contributing to the market include the escalating demand for preoperative and postoperative critical care services, the rising prevalence of lifestyle-related diseases, growing expenditure on patient care, and increasing investments for improving the number of beds to patient ratio.
IMARC Group provides an analysis of the key trends in each sub-segment of the global therapeutic beds market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
Clinical Beds
Regular Beds
ICU Beds
Pediatric Beds
Birthing Beds
Bariatric Beds
Low Air Loss Beds
Others
Household Beds
Accessories
Acute Care Beds
Critical Care Beds
Long-term Beds
Hospital and Clinics
Reproductive Care Centers
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amico Group of Companies, Arjo AB, Centrobed Ltd., GF Health Products Inc., HARD Manufacturing Company Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Medical Depot Inc. (DBA Drive DeVilbiss Healthcare), Medline Industries LP and Stryker Corporation.